Mitochondrial transplantation is currently being explored as a means to repair and restore proper organelle function in a variety of inherited and acquired disorders of energy metabolism. The optimal preparation and application of donor mitochondria is unknown, but most studies in vivo have used injection techniques or, for tissue studies, unpackaged mitochondria (organelles isolated and suspended in buffer) in transplant experiments. Packaging in lipid rafts can increase recipient cell uptake of some compounds and objects. We present the first data comparing recipient cell uptake of unpackaged mitochondria to recipient cell uptake of mitochondria packaged in cell membrane lipids. Mitochondria and membranes were prepared from autologous cells and applied to cells (fibroblasts) in culture. Both unpackaged and lipid-packaged mitochondria were taken into recipient cells and the donor mitochondria showed evidence, in each case, of retained functionality and the ability to merge with the recipient mitochondrial matrix. However, lipid packaging appeared to enhance the uptake of functional mitochondria. Current studies of mitochondrial transplantation in animal models might fruitfully explore the utility and efficacy of lipid-packaged mitochondria in transplant experiments.
Introduction
Mitochondria are essential organelles in all eukaryotic cells. They appear to have originated from engulfed prokaryotes, and they play a key role in bioenergetic processes, especially oxidative phosphorylation and the aerobic metabolism of glucose and fat. They also play a central role in calcium storage and signaling and in apoptosis 3 (1, 2) . The human mitochondrial genome is maternally inherited, small, at 16,568 bp, and encodes only a limited number of mitochondria-specific proteins, rRNAs, and tRNAs (3) . All other mitochondrial proteins are encoded by the nuclear genome.
Notably, the mitochondrial genome undergoes a high rate of mutation because mtDNA is not protected by histones, is inefficiently repaired (4) and is exposed to oxygen radicals generated by oxidative phosphorylation (1) .
A large number of heritable diseases are caused by mutations in mitochondrial and nuclear genes encoding mitochondrial proteins. Many produce heritable neurologic syndromes and skeletal or cardiac myopathies (1, 3, 5, 6) . In addition, environmentally induced mutations in mtDNA have been implicated in commonly acquired disorders, including ischemic diseases of the heart and brain, neurodegenerative diseases, some liver diseases, and some cancers (5, 7) . Mitochondrial compromise appears especially relevant to normal brain and muscle function, as these tissues use far more energy per unit weight than other tissues of the body. Thus, mitochondrial dysfunctions are often observed in neuropsychiatric disease, including bipolar disorders (BD), depressive disorders, schizophrenias, and Rett's syndrome; neurodegenerative disease like Alzheimer's disease, Parkinson's disease, Friedeich's ataxia (and other ataxias); amyotrophic lateral sclerosis (ALS) (and other motor neuron diseases); Huntington's disease; and various neuropathies and myopathies, such as Leber's hereditary optic neuropathy (LHON), encephalopathies, lactic acidosis, stroke syndromes (MELAS); macular degeneration; epilepsies; and mitochondrial myopathies. Of great importance, mitochondrial structural integrity and functional efficiency declines with age, and 4 mitochondrial alterations may be a key determinant of age related reductions in tissue health, even in the absence of pathology (8) .
Mitochondrial networks are highly dynamic (9) . Within cells, the networks expand and contract, in response to local signals. Through budding and fission, new mitochondria leave the local network. Simultaneously, fusion of existing mitochondria occurs between contiguous networks (10) . These activities suggest that mitochondrial pathologies might be addressed by altering mitochondrial growth and connectivity or by replacing damaged mitochondria (11) .
Pharmacologic and nutritional precursor approaches to enhance mitochondrial function and biogenesis are being studied, but have not yet produced successful treatment strategies (11, 12) .
In in vitro cell culture, intercellular transfer of functionally competent mitochondria has been observed, and this mechanism may improve local mitochondrial deficiencies or compensate for defective mitochondria (13) . Mimicking this natural mechanism, the replacement or transplant of compromised mitochondria with healthy exogenous organelles might have therapeutic potential. We have proposed techniques and uses for such replacement therapies (14) and there have been increasing numbers of reports of mitochondrial transplantation in both in vitro and in vivo studies. Transplantation methods vary by study, but include direct injections of mitochondria and various techniques to induce fusion of cells to allow transfer of mitochondria through cell 5 membranes (Reviewed by McCully, 2016 (15) ). One technique, not yet reported, involves the use of lipid rafts. These have been used elsewhere to induce cells to engulf exogenous substances and organelles. We hypothesized that this packaging could be useful to enhance mitochondrial transplantation or uptake, as well.
In this study, we compare the efficiency of recipient cell uptake of mitochondria following the delivery of donor mitochondria in buffer solution to donor mitochondria mixed with lipid rafts derived from the recipient cells' outer membrane. Our hypothesis was that preparations mixed with lipid membranes would achieve better incorporation into recipient cells. Higher incorporation of transplanted mitochondria might be important for achieving therapeutic benefits.
Materials and methods:

Cell culture
Human fibroblasts were established from skin biopsy samples from study participants at McLean Hospital (Belmont, MA). Study procedures were approved by the McLean Hospital Institutional Review Board, and all subjects gave written consent to participate after procedures and possible side effects were explained. Fibroblasts were expanded in cell culture media (Minimal Essential Medium, NEAA (Gibco, ThermoFisher) supplemented with 15% fetal bovine serum, 1% GlutaMAX (Gibco, ThermoFisher), and 1% Penicillin-streptomycin in 5% CO 2 at 37°C. Media was changed every other day. 1X
TrypLE Express Enzyme (Gibco, ThermoFisher) was used for passaging cells. Cell lines used for experiments were all between passages P5 and P7.
Isolation of mitochondria
Mitochondria were isolated from fibroblasts using a modified protocol from Frezza et al., 2007 (16) . Ten mL of IB C buffer (1 mL of 0.1 M Tris/MOPS, 100 uL of 0.1 M EGTA/Tris, and 2 mL of 1 M sucrose diluted with distilled water, pH 7.4) was prepared and kept on ice. Two days prior to the experiment, cells were plated to reach 80-85% confluence on the day of the experiment. On the day of the experiment, cells were washed twice with DPBS (without Ca 2+ and Mg 2+ ) and detached using 1X TrypLE Express Enzyme. Cells were resuspended in cell culture media and transferred to a new conical tube, centrifuged for three minutes at 600 g and then counted. 2 x 10 7 fibroblasts were transferred to a separate tube and centrifuged for ten minutes at 600 g. The supernatant was discarded and the cell pellet was resuspended in IB C buffer. Cells were then homogenized using a 22G needle until at least 50% of the cells were damaged (determined by visual check under a microscope), then the resulting homogenate was centrifuged for ten minutes at 600 g at 4°C. The supernatant was collected, transferred to a pre-chilled microcentrifuge tube, and centrifuged for ten minutes at 7,000 g at 4°C. The supernatant was discarded and the pellet was resuspended in IB C buffer. The pellet suspension was centrifuged again for ten minutes at 7,000 g at 4°C. The supernatant was discarded and the pellet containing the isolated mitochondria was carefully resuspended in IB C buffer to avoid the formation of bubbles and kept on ice.
Assessing the purity and membrane intactness of mitochondrial isolates
Donor mitochondria were isolated, pelleted, and fixed in 2% glutaraldehyde, 100 mM 7 sodium cacodylate buffer, 2 mM CaCl 2 (pH 7.4). Mitochondrial pellets were processed following standard electron microscopy protocols. All chemicals were from Ted Pella, Inc. (Redding, CA). Briefly, mitochondrial pellets were postfixed in 1% OsO 4 , dehydrated in a series of alcohols up to absolute alcohol and then transitioned to propylene oxide and embedded in Epon. Blocks were sectioned, stained, and examined on a JEOL 1200EX microscope. Electron microscopy was used to determine the presence of cristae, and the presence of the inner and outer membranes of the mitochondria as an indication of the intactness of mitochondrial membranes. Western blots of isolated mitochondria were also run and probed with an antibody to TOM-20, a specific marker protein for mitochondrial outer membrane, in order to test for enrichment and confirm intactness of mitochondria in the mitochondrial isolates.
Assessing the functional status of mitochondrial preparations
The functional status of isolated mitochondria was assessed by incubating an aliquot of the mitochondrial preparation with the dye JC-1 following manufacturer's (Life Technologies) protocols. The aliquot was visualized under a fluorescent microscope using a filter set with 488nm excitation and 510nm emission for the green channel and a filter set with a 549nm excitation and 575nm emission for the red channel. JC-1 is an indicator of mitochondrial membrane potential. In healthy mitochondria, JC-1 accumulates and forms aggregates that fluoresce red, while at depolarized membrane potentials, JC-1 exists as a green-fluorescent monomer.
Recipient fibroblasts 8
Two days prior to the experiment, recipient fibroblasts were plated at 2.1 x 10 4 cells per well in all four wells of Lab-Tek II chamber coverglasses (Nunc) coated with fibronectin (5 ug/mL final concentration).
Labeling donor and recipient fibroblast mitochondria
Sixteen hours prior to the experiment, donor fibroblasts were infected with either HSV- 
Preparation of Detergent-free lipid rafts
Detergent-free lipid rafts were isolated from fibroblasts using a modified protocol from
Macdonald and Pike (17) . All procedures were done on ice. was layered on top of this mixture. The gradient was centrifuged for 90 minutes at 52,000g using an SW-41 rotor in a Beckman ultracentrifuge. After centrifugation, a distinct band containing the lipid rafts, visible between the 20% and 25% layers, was removed using a 20G needle, transferred to a fresh microcentrifuge tube, and kept on ice.
Mitochondrial transplantation
Donor mitochondria (expressing DsRed2) with and without lipid rafts were transplanted into autologous recipient fibroblasts. To verify that there was no cross contamination, two side-by side control conditions were also tested: rafts only and recipient cells only.
Immediately prior to transplantation, mitochondria isolated from donor cells were gently resuspended in 100ul of imaging media (MEM without phenol red and glutamine, plus 10% fetal bovine serum, and 1% GlutaMax) and divided into two samples to be prepared, with and without lipid rafts. The four conditions to be tested were prepared as 
Imaging mitochondria in recipient fibroblasts
After incubation of the preparations, as described above, cells were fixed in 4% paraformaldehyde in 100 mM phosphate buffer, pH 7.4, and mitochondrial uptake was assessed using a fluorescent Zeiss Observer Z.1 microscope. Donor mitochondria labeled with DsRed2 were visualized at excitation (549 nm) and emission (575 nm).
Recipient mitochondria labeled with Mitochondria-GFP were visualized at excitation 11 (488 nm) and emission (510 nm). Recipient nuclei were visualized at excitation and emission of 350 nm and 461 nm. Images were taken at 40X. Additional studies using confocal microscopy were done to assess the results of a randomly chosen sub-sample of the transplantations. Confocal microscopy was performed on a laser scanning confocal microscope (SP8-TCS, Leica). Eight Z stack images, with Z section intervals of 0.75µm (using a 40X 1.3NA lens) of fields of cells were acquired at excitation wavelengths of 405, 488 and 561 nm. This Z section interval, somewhat smaller than the average mitochondrial diameter, provided adequate resolution to observe whether your recipient and donor mitochondria remain physically separate. 
Quantification of donor recipient cells taking up donor mitochondria
Results and Discussion:
Unpackaged mitochondria and lipid-packaged mitochondria were prepared in parallel and recipient cells were exposed at the same time, to enhance accuracy of comparisons. Figure 1 shows that the isolated mitochondria for donor preparations were structurally intact and functionally competent, as evidenced by red JC-1 staining (A) and the presence of intact cristae and two membranes on the EM level (B).
Additionally, western blots of the mitochondrial isolates show an increased signal for TOM-20 indicating mitochondrial enrichment in the isolates versus unprepared lysates (data not shown).
Uptake of mitochondria by recipient cells was observed in both unpackaged mitochondria and mitochondria packaged in lipid rafts (Figure 2 ). Both red donor mitochondria and green recipient mitochondria are visible as well as some instances of potential mitochondrial fusion (yellow). Most mitochondria exist in networks, and the observed fusion may be between mitochondrial networks, rather than isolated mitochondria.
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Relative efficiency of uptake is shown in Figure 3 . 
